Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors.
Lipin 1 is a bifunctional protein that regulates gene transcription and, as a Mg(2+)-dependent phosphatidic acid phosphatase (PAP), is a key enzyme in the biosynthesis of phospholipids and triacylglycerol. We describe here the functional interaction between lipin 1 and the nuclear factor of activated T cells c4 (NFATc4). Lipin 1 represses NFATc4 transcriptional activity through protein-protein interaction, and lipin 1 is present at the promoters of NFATc4 transcriptional targets in vivo. Catalytically active and inactive lipin 1 can suppress NFATc4 transcriptional activity, and this suppression may involve recruitment of histone deacetylases to target promoters. In fat pads from mice deficient for lipin 1 (fld mice) and in 3T3-L1 adipocytes depleted of lipin 1 there is increased expression of several NFAT target genes including tumor necrosis factor alpha, resistin, FABP4, and PPARgamma. Finally, both lipin 1 protein and total PAP activity are decreased with increasing adiposity in the visceral, but not subcutaneous, fat pads of ob/ob mice. These observations place lipin 1 as a potentially important link between triacylglycerol synthesis and adipose tissue inflammation.
Kim
Hyun Bae
HB
Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Kumar
Anil
A
Wang
Lifu
L
Liu
Guang-Hui
GH
Keller
Susanna R
SR
Lawrence
John C
JC
Finck
Brian N
BN
Harris
Thurl E
TE
D041721:3T3-L1 Cells; D017667:Adipocytes / Q000187:drug effects / Q000378:metabolism*; D000375:Aging / Q000378:metabolism; D000818:Animals; D020013:Calcium Signaling / Q000187:drug effects; D004247:DNA / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects; D006655:Histone Deacetylases / Q000378:metabolism; D006877:Hydroxamic Acids / Q000494:pharmacology; D018836:Inflammation Mediators / Q000378:metabolism*; D051379:Mice; D050778:NFATC Transcription Factors / Q000235:genetics*; D009687:Nuclear Proteins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D009765:Obesity / Q000235:genetics; D047493:PPAR alpha / Q000378:metabolism; D000071248:Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; D010711:Phosphatidate Phosphatase; D011401:Promoter Regions, Genetic / Q000235:genetics; D011485:Protein Binding / Q000187:drug effects; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012097:Repressor Proteins / Q000378:metabolism*; D015534:Trans-Activators / Q000378:metabolism; D014157:Transcription Factors; D014158:Transcription, Genetic / Q000187:drug effects; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000378:metabolism
D006877:Hydroxamic Acids; D018836:Inflammation Mediators; D050778:NFATC Transcription Factors; C467907:Nfatc4 protein, mouse; D009687:Nuclear Proteins; D047493:PPAR alpha; D000071248:Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; C485290:Ppargc1a protein, mouse; D012333:RNA, Messenger; D012097:Repressor Proteins; D015534:Trans-Activators; D014157:Transcription Factors; D014409:Tumor Necrosis Factor-alpha; C012589:trichostatin A; D004247:DNA; C418978:Lpin1 protein, mouse; D010711:Phosphatidate Phosphatase; D006655:Histone Deacetylases
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):1047-52
11792863
Prog Lipid Res. 2004 Mar;43(2):134-76
14654091
Mol Cell. 1998 Apr;1(5):627-37
9660947
PLoS One. 2009 Sep 15;4(9):e7031
19753306
Nucleic Acids Res. 2001 May 1;29(9):e45
11328886
J Biol Chem. 2006 Apr 7;281(14):9210-8
16467296
Cell Metab. 2005 Jan;1(1):73-83
16054046
Mol Cell Biol. 2002 Jun;22(11):3892-904
11997522
Mol Cell Biol. 2006 Oct;26(20):7372-87
16908540
Genes Dev. 2003 Sep 15;17(18):2205-32
12975316
J Lipid Res. 2000 Jul;41(7):1067-76
10884287
J Biol Chem. 1989 May 15;264(14):7994-8003
2722772
Proc Soc Exp Biol Med. 1976 Dec;153(3):476-82
1013161
EMBO J. 2005 Jun 1;24(11):1931-41
15889145
Nat Genet. 2001 Jan;27(1):121-4
11138012
J Biol Chem. 2003 May 2;278(18):15874-85
12606546
Proc Natl Acad Sci U S A. 2004 May 18;101(20):7554-9
15131267
J Biol Chem. 2010 Feb 5;285(6):3857-3864
19955570
FEBS Lett. 2008 Jan 9;582(1):90-6
18023282
Cell Metab. 2006 Sep;4(3):199-210
16950137
Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1502-9
18940942
J Clin Invest. 2008 Sep;118(9):2992-3002
18769626
Int J Obes (Lond). 2007 Mar;31(3):449-56
16847472
Mol Cell Biol. 2008 May;28(10):3489-501
18347059
J Biol Chem. 2005 Sep 23;280(38):32883-9
16049017
J Biol Chem. 1994 Dec 2;269(48):30445-50
7982959
Biochim Biophys Acta. 1981 Jul 24;665(1):145-53
7284412
J Biol Chem. 2009 Mar 13;284(11):6763-72
19136718
Diabetes. 2007 Sep;56(9):2395-9
17563064
J Lipid Res. 2005 Nov;46(11):2347-55
16150820
Annu Rev Immunol. 1997;15:707-47
9143705
J Lipid Res. 2008 Jul;49(7):1519-28
18362392
Biochim Biophys Acta. 2008 May;1783(5):713-27
18241676
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15537-41
9861004
Mol Cell. 2002 Nov;10(5):1071-81
12453415
Am J Physiol Lung Cell Mol Physiol. 2006 Aug;291(2):L257-64
16489119
J Biol Chem. 2002 Dec 20;277(51):49776-81
12351639
Science. 1993 Jan 1;259(5091):87-91
7678183
J Biol Chem. 2008 Dec 12;283(50):34896-906
18930917
J Biol Chem. 2007 Jan 5;282(1):277-86
17105729
J Biol Chem. 2004 Jul 9;279(28):29558-64
15123608
Am J Physiol Endocrinol Metab. 2007 Sep;293(3):E713-25
17578885
Biochim Biophys Acta. 2009 Jun-Aug;1789(6-8):451-9
19616654
J Nutr. 2004 Oct;134(10):2673-7
15465765
J Lipid Res. 2009 Jun;50(6):1185-94
19201733
J Lipid Res. 2007 Jan;48(1):201-6
17035674
Prog Lipid Res. 1984;23(3):115-33
6100459
J Biol Chem. 2003 May 9;278(19):17246-54
12598522
J Lipid Res. 2008 Dec;49(12):2493-503
18791037
J Biol Chem. 2007 Dec 21;282(51):37026-35
17971454
Diabetologia. 1968 Jun;4(3):141-9
5738353
Diabetes. 2006 Oct;55(10):2811-8
17003347
Curr Opin Lipidol. 2009 Jun;20(3):165-70
19369868
J Biol Chem. 2007 Feb 9;282(6):3450-7
17158099
Metabolism. 2007 Nov;56(11):1518-26
17950103
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19637-42
19060202
Cell. 2004 Sep 3;118(5):649-63
15339668